IGF1 and prostate cancer: It has been suggested that the inverse association between diabetes and prostate cancer risk might be due to lower circulating concentrations of IGF-I (Teppala & Shankar, 2010) and/or testosterone (Grossmann, 2011) or to potential anti-carcinogenic properties of diabetes medication (Wright and Stanford, 2009).